Secondary Osteoporosis: Causes and When to Suspect It

The distinction between primary and secondary osteoporosis represents one of the most clinically important separations in bone health. Primary osteoporosis develops as part of the typical aging process or postmenopausal hormonal changes, with no specific underlying disease driving the bone loss. Secondary osteoporosis develops as a consequence of another medical condition, medication, or various other identifiable causes. The distinction matters substantially because secondary osteoporosis often cannot be effectively managed by addressing bone health alone. Without identifying and treating the underlying cause, bone loss may continue despite appropriate osteoporosis-specific treatment.

The clinical importance of recognizing secondary osteoporosis reflects substantial implications for management. A patient with celiac disease causing malabsorption-driven osteoporosis needs treatment of the celiac disease in addition to or even prior to osteoporosis-specific medications. A patient with Cushing syndrome producing osteoporosis through excess cortisol needs the underlying endocrine disorder addressed. A patient with secondary osteoporosis from a medication may benefit from medication review and modification when possible.

The clinical clues that should raise suspicion of secondary osteoporosis include unusual age at diagnosis, unusual fracture patterns, severe disease, lack of response to standard treatment, and various other features. Younger adults with osteoporosis particularly warrant evaluation for secondary causes. Premenopausal women with osteoporosis warrant evaluation. Men with osteoporosis warrant evaluation. Severe disease at any age warrants evaluation. Lack of response to typical treatment warrants reassessment.

For more on causes, see Osteoporosis: Causes, Symptoms, Diagnosis, Fracture Risk, and Treatment (Complete Guide).

⸻

Primary vs Secondary Osteoporosis

Primary Osteoporosis

Primary osteoporosis develops as part of the typical aging process or postmenopausal hormonal changes, without a specific underlying disease driving the bone loss. It is sometimes divided into Type I (postmenopausal) osteoporosis related to estrogen deficiency, and Type II (senile) osteoporosis related to age-related bone loss in older adults of both sexes. Primary osteoporosis is the most common form.

Secondary Osteoporosis

Secondary osteoporosis develops as a consequence of another medical condition, medication, or other identifiable cause. The cause may be identified before the osteoporosis is recognized, or osteoporosis may be the first indication of an underlying condition.

Why the Distinction Matters

Identification of underlying causes affects treatment decisions. Some causes can be addressed directly, potentially improving bone health. Treatment of osteoporosis alone may not be sufficient when secondary causes continue. Various complications beyond bone health may exist with the underlying conditions.

Estimates suggest approximately 30% of postmenopausal women and 50% of men with osteoporosis may have secondary causes contributing.

For more on causes, see What Causes Osteoporosis? Risk Factors Explained.

⸻

Endocrine Causes

Cushing Syndrome

Cushing syndrome involves excess cortisol from various causes including endogenous overproduction or chronic exogenous corticosteroid use. Excess cortisol affects bone health through reduced osteoblast activity, increased osteoclast activity, and various other mechanisms — producing substantial osteoporosis with high fracture risk. Treatment of the underlying cause supports bone health, though some effects may persist.

Hyperthyroidism

Hyperthyroidism (excess thyroid hormone) accelerates bone turnover with corresponding bone loss. The condition can result from primary thyroid disease or excessive thyroid hormone replacement. Treatment of hyperthyroidism supports bone health.

Hyperparathyroidism

Hyperparathyroidism (excess parathyroid hormone) promotes bone resorption and calcium release from bone. Primary hyperparathyroidism from parathyroid adenoma or hyperplasia is the most common form. Treatment, often surgical for primary hyperparathyroidism, supports bone health.

Hypogonadism in Men

Hypogonadism (testosterone deficiency) in men substantially affects bone health through various conditions including primary testicular dysfunction. Testosterone replacement supports bone health when appropriate.

Premature Ovarian Insufficiency in Women

Premature ovarian insufficiency (premature menopause before age 40) extends the period of estrogen-deficient bone loss. Hormone replacement therapy is typically appropriate to mitigate bone effects.

Diabetes Mellitus

Diabetes mellitus, particularly type 1 and uncontrolled type 2, affects bone health through multiple mechanisms. Type 1 diabetes is associated with reduced bone density. Type 2 diabetes can be associated with normal or even increased bone density but with increased fracture risk despite this, reflecting altered bone quality.

⸻

Gastrointestinal Causes

Celiac Disease

Celiac disease impairs absorption of various nutrients including calcium and vitamin D, with substantial bone effects. Untreated celiac disease can produce osteoporosis, sometimes as the only or initial manifestation. Effective gluten-free dietary management typically improves bone health.

Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) including Crohn disease and ulcerative colitis affects bone health through impaired absorption, inflammation effects, corticosteroid use in treatment, reduced physical activity from disease, and various others. Comprehensive management addresses bone health alongside the underlying disease.

Bariatric Surgery

Bariatric surgery, particularly gastric bypass, can affect calcium and vitamin D absorption with bone implications. The effects vary among different procedures. Long-term monitoring after bariatric surgery includes bone health assessment.

Chronic Liver Disease and Pancreatic Insufficiency

Chronic liver disease affects vitamin D metabolism and various other aspects of bone health. Pancreatic insufficiency affects fat absorption with implications for fat-soluble vitamins including vitamin D.

⸻

Chronic Kidney Disease

Chronic kidney disease (CKD) affects bone health through multiple mechanisms: reduced vitamin D activation by kidneys, phosphate retention, secondary hyperparathyroidism, acidosis effects on bone, and various others. The combination produces what is called CKD-mineral and bone disorder (CKD-MBD).

The bone effects of CKD include various patterns: osteomalacia (softening of bones from impaired mineralization), high-turnover bone disease, low-turnover bone disease (adynamic bone disease), and mixed patterns. Management involves addressing the underlying CKD and specific bone-related issues, differing from typical osteoporosis management.

⸻

Rheumatologic Conditions

Rheumatoid arthritis affects bone health through direct effects of inflammation on bone, reduced physical activity from joint disease, corticosteroid use in treatment, and various others. Aggressive treatment with disease-modifying therapies has improved bone outcomes. Ankylosing spondylitis and various other inflammatory conditions including systemic lupus erythematosus and vasculitis can also affect bone health.

⸻

Cancer and Cancer Treatments

Direct Bone Effects

Multiple myeloma is a blood cancer that directly affects bone, often producing characteristic lytic bone lesions. Various cancers can also metastasize to bone, producing bone lesions and fracture risk — common examples include breast cancer, prostate cancer, lung cancer, and kidney cancer.

Treatment-Related Bone Effects

Aromatase inhibitors used for hormone-positive breast cancer reduce estrogen levels with corresponding bone effects — specific monitoring and often bone-protective treatment is appropriate. Androgen deprivation therapy used for prostate cancer reduces testosterone with corresponding bone effects. Various chemotherapy agents and radiation therapy to bone-containing areas can also affect bone health.

For more on imaging, see Bone Density Test (DXA): What It Is and How to Read Results.

⸻

Eating Disorders

Eating disorders, particularly anorexia nervosa, produce substantial bone effects through reduced caloric and nutrient intake, hormonal effects including estrogen deficiency from amenorrhea, stress hormone effects, and various others. The bone effects can be substantial, with some patients developing osteoporosis at very young ages. Bone effects partially improve with weight restoration and treatment of the underlying disorder, though full recovery may not occur.

⸻

Medications That Cause Secondary Osteoporosis

Corticosteroids

Corticosteroids are among the most important medications affecting bone health. Long-term oral corticosteroid use produces substantial bone loss — the effects are dose-dependent and time-dependent, with substantial losses possible in the first 6 to 12 months. Even relatively low doses (such as 5 mg of prednisone daily) for prolonged periods can affect bone health. Patients on long-term corticosteroids warrant specific attention to bone health and often bone-protective treatment.

Other Medications

Various anticonvulsants affect bone health through effects on vitamin D metabolism. SSRIs may affect bone health with prolonged use. Proton pump inhibitors (PPIs) may affect calcium absorption with prolonged use. Loop diuretics increase calcium excretion with potential bone effects. Long-term heparin use can affect bone health. Various other medications including some immunosuppressants and some HIV medications can also affect bone health.

For more on causes broadly, see What Causes Osteoporosis? Risk Factors Explained.

⸻

When to Suspect Secondary Osteoporosis

Several specific situations warrant evaluation for secondary causes:

• Unusual age at diagnosis — younger adults, premenopausal women, and children with osteoporosis warrant evaluation.
• Men with osteoporosis — higher prevalence of secondary causes compared to postmenopausal women.
• Severe or rapidly progressive disease — at any age, may suggest contributing factors beyond aging alone.
• Multiple fragility fractures or unusual fracture patterns.
• Lack of response to standard treatment — continued bone loss or fractures despite treatment may indicate ongoing contributing factors.
• Specific clinical features suggesting other conditions (features of Cushing syndrome, hyperthyroidism, celiac disease, etc.).
• Family history of osteogenesis imperfecta, rare genetic conditions, or various others.

For more on testing, see Bone Density Test (DXA): What It Is and How to Read Results.

⸻

Evaluation Approach

Clinical History and Examination

Detailed clinical history addresses personal medical history, family history, medications (current and past), lifestyle factors, and symptoms suggesting specific conditions. Physical examination identifies clinical findings of various potential underlying conditions.

Initial Laboratory Testing

Initial laboratory testing typically includes: complete blood count, comprehensive metabolic panel, calcium (total and ionized), phosphorus, magnesium, vitamin D (25-hydroxyvitamin D), parathyroid hormone (PTH), thyroid stimulating hormone (TSH), and 24-hour urine calcium and creatinine.

Specific Disease Testing

• Celiac disease: tTG-IgA antibody and total IgA.
• Cushing syndrome: 24-hour urine free cortisol, late-night salivary cortisol, or low-dose dexamethasone suppression test.
• Hypogonadism in men: Total testosterone.
• Multiple myeloma: Serum protein electrophoresis with immunofixation, urine protein, free light chains.

Imaging beyond bone density testing and specialist evaluation may be appropriate based on the clinical situation.

For more on specific causes, see What Causes Osteoporosis? Risk Factors Explained.

⸻

Implications for Treatment

Treatment of underlying causes is the foundation of management. For some causes, definitive treatment substantially improves bone health; for others, ongoing management addresses the underlying issue while bone-specific treatment continues. Modification of contributing medications may be appropriate when possible, or alternative medications with less bone effect may be considered. Bone-specific treatment is often added to treatment of underlying causes. Comprehensive management addresses both the underlying cause and bone health together, with monitoring of both.

For more on prevention, see How to Prevent Osteoporosis: Lifestyle and Nutrition.

⸻

Common Misconceptions

• All osteoporosis is just aging — A substantial proportion involves secondary causes that warrant identification.
• Secondary causes only affect younger patients — Secondary causes can affect patients at any age.
• Treating bone alone is sufficient — Without addressing underlying causes, bone treatment may be inadequate.
• Secondary causes are always obvious — Some causes can be subtle; comprehensive evaluation is needed.
• Once identified, secondary causes always resolve — Some are chronic and require ongoing management.
• Secondary causes are just theoretical — They are common and clinically important.

For more on related considerations, see Most Commonly Misdiagnosed Conditions.

⸻

Special Patient Populations

Younger adults with osteoporosis particularly warrant evaluation — the unusual age suggests likely contributing factors. Premenopausal women warrant comprehensive evaluation given that primary osteoporosis is uncommon in this group. Men with osteoporosis warrant evaluation given higher prevalence of secondary causes, with hypogonadism evaluation being particularly important. Patients on long-term corticosteroids warrant specific bone health management. Patients with eating disorders warrant attention to bone health as part of comprehensive care. Cancer patients receiving bone-affecting treatments warrant specific monitoring. Patients with chronic kidney disease have specific patterns of bone disease requiring specialized management.

For more on different presentations, see Osteoporosis in Women vs Men: Key Differences.

⸻

When to See a Specialist

Primary care physicians manage many patients but refer for complex cases. Endocrinologists evaluate patients with suspected hormonal causes. Rheumatologists, gastroenterologists, nephrologists, oncologists, and hematologists each address their respective causes. For complex situations including multiple potential causes, unusual presentations, or various other challenges, evaluation at major medical centers with comprehensive bone health programs provides specialized expertise.

⸻

Conclusion

Secondary osteoporosis develops as a consequence of another medical condition, medication, or other identifiable cause. The distinction from primary osteoporosis matters substantially because identification of underlying causes affects treatment decisions and outcomes.

Endocrine causes include Cushing syndrome, hyperthyroidism, hyperparathyroidism, hypogonadism in men, premature ovarian insufficiency in women, diabetes mellitus, and growth hormone deficiency. Gastrointestinal causes include celiac disease (which can present as osteoporosis), inflammatory bowel disease, bariatric surgery, chronic liver disease, and pancreatic insufficiency. Chronic kidney disease produces CKD-mineral and bone disorder through multiple mechanisms.

Rheumatologic conditions, cancer and cancer treatments, eating disorders, and various medications — most importantly corticosteroids — all represent important secondary causes. When to suspect secondary osteoporosis includes unusual age, men with osteoporosis, severe or progressive disease, lack of treatment response, and specific clinical features.

Evaluation involves comprehensive clinical assessment and targeted laboratory testing. Treatment addresses underlying causes alongside bone-specific therapy. Identification of secondary causes can substantially improve outcomes — the combination of comprehensive evaluation with appropriate management provides the foundation for the best possible results.

⸻

Medical Disclaimer

This content is for informational purposes only and does not constitute medical advice. Individuals should consult a qualified healthcare provider for diagnosis and treatment.